Evidence map›Paper›PMID 42165168›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

A Cascade-Activatable Prodrug Nanomedicine for Photothermally Augmented in Situ Synergistic Chemo/Chemodynamic Therapy.

Jinghang Li, Bang Liu, Hua Su, Ming Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinghang LiSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Bang LiuSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Hua SuSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Ming LiSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.

Funding

Hunan Provincial Science & Technology Program 2017XK2027National Natural Science Foundation of China 51871246
6 · The paper itself

Abstract

Prodrug nanomedicine represents a promising strategy to enhance tumor-selective drug activation while minimizing systemic toxicity in cancer treatment. Herein, we develop a cascade-activatable prodrug nanoplatform, AuSt@MOS-Cu

Indexed as

NanomedicinePhotothermal TherapyProdrugsAnimalsCell Line, TumorCopperDisulfiramFemaleGlutathioneHumansMiceTumor MicroenvironmentCopperDisulfiramGlutathioneProdrugscascade activationchemotherapydisulfiramprodrug nanomedicineresponsive degradation

Identifiers

PMID42165168
PMCPMC13360368

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.